Fecal Transplants: What Is Being Transferred?

PLoS Biol. 2016 Jul 12;14(7):e1002503. doi: 10.1371/journal.pbio.1002503. eCollection 2016 Jul.

Abstract

Fecal transplants are increasingly utilized for treatment of recurrent infections (i.e., Clostridium difficile) in the human gut and as a general research tool for gain-of-function experiments (i.e., gavage of fecal pellets) in animal models. Changes observed in the recipient's biology are routinely attributed to bacterial cells in the donor feces (~1011 per gram of human wet stool). Here, we examine the literature and summarize findings on the composition of fecal matter in order to raise cautiously the profile of its multipart nature. In addition to viable bacteria, which may make up a small fraction of total fecal matter, other components in unprocessed human feces include colonocytes (~107 per gram of wet stool), archaea (~108 per gram of wet stool), viruses (~108 per gram of wet stool), fungi (~106 per gram of wet stool), protists, and metabolites. Thus, while speculative at this point and contingent on the transplant procedure and study system, nonbacterial matter could contribute to changes in the recipient's biology. There is a cautious need for continued reductionism to separate out the effects and interactions of each component.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Enterocolitis, Pseudomembranous / therapy
  • Fatty Acids / metabolism
  • Fecal Microbiota Transplantation*
  • Feces / microbiology
  • Gastrointestinal Microbiome*
  • Gastrointestinal Tract / microbiology
  • Humans

Substances

  • Fatty Acids

Grants and funding

This work was supported by National Science Foundation Awards DEB 1046149 and IOS 1456778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.